Acute Shift in Glutamate Concentrations Following Experimentally Induced Panic with Cholecystokinin Tetrapeptide—A 3T-MRS Study in Healthy Subjects

According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine (Glx) levels were measured during cholecystokinin-tetrapeptide (CCK-4)-induced panic using magnetic re...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychopharmacology (New York, N.Y.) Vol. 38; no. 9; pp. 1648 - 1654
Main Authors Zwanzger, Peter, Zavorotnyy, Maxim, Gencheva, Elena, Diemer, Julia, Kugel, Harald, Heindel, Walter, Ruland, Tillmann, Ohrmann, Patricia, Arolt, Volker, Domschke, Katharina, Pfleiderer, Bettina
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine (Glx) levels were measured during cholecystokinin-tetrapeptide (CCK-4)-induced panic using magnetic resonance spectroscopy (MRS). Eighteen healthy subjects underwent a CCK-4 challenge. MR spectra were obtained from the anterior cingulate cortex (ACC) using a single voxel point-resolved spectroscopy method and analyzed using LCModel. A combined fitting of Glx was performed. Panic was assessed using the Acute Panic Inventory (API) and Panic Symptom Scale (PSS) scores. Moreover, hypothalamic-pituitary-adrenal axis stimulation was monitored throughout the challenge. There was a significant panic response following CCK-4 as revealed by a marked increase in both the panic scores (API: F(1,17)=149.41; p<0.0001; PSS: F(1,17)=88.03; p<0.0001) and heart rate (HR: F(1,17)=72.79; p<0.0001). MRS measures showed a significant increase of brain Glx/creatine (Glx/Cr) levels peaking at 2-10 min after challenge (F(1,17)=15.94; p=0.001). There was also a significant increase in CCK-4-related cortisol release (F(6,11)=8.68; p=0.002). Finally, significant positive correlations were found between baseline Glx/Cr and both APImax (r=0.598; p=0.009) and maximum heart rate (HR(max)) during challenge (r=0.519; p=0.027). Our results suggest that CCK-4-induced panic is accompanied by a significant glutamate increase in the bilateral ACC. The results add to the hypothesis of a disturbance of the inhibitory-excitatory equilibrium and suggest that apart from static alterations rapid and dynamic neurochemical changes might also be relevant for the neural control of panic attacks.
AbstractList According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine (Glx) levels were measured during cholecystokinin-tetrapeptide (CCK-4)-induced panic using magnetic resonance spectroscopy (MRS). Eighteen healthy subjects underwent a CCK-4 challenge. MR spectra were obtained from the anterior cingulate cortex (ACC) using a single voxel point-resolved spectroscopy method and analyzed using LCModel. A combined fitting of Glx was performed. Panic was assessed using the Acute Panic Inventory (API) and Panic Symptom Scale (PSS) scores. Moreover, hypothalamic-pituitary-adrenal axis stimulation was monitored throughout the challenge. There was a significant panic response following CCK-4 as revealed by a marked increase in both the panic scores (API: F(1,17)=149.41; p<0.0001; PSS: F(1,17)=88.03; p<0.0001) and heart rate (HR: F(1,17)=72.79; p<0.0001). MRS measures showed a significant increase of brain Glx/creatine (Glx/Cr) levels peaking at 2-10 min after challenge (F(1,17)=15.94; p=0.001). There was also a significant increase in CCK-4-related cortisol release (F(6,11)=8.68; p=0.002). Finally, significant positive correlations were found between baseline Glx/Cr and both APImax (r=0.598; p=0.009) and maximum heart rate (HR(max)) during challenge (r=0.519; p=0.027). Our results suggest that CCK-4-induced panic is accompanied by a significant glutamate increase in the bilateral ACC. The results add to the hypothesis of a disturbance of the inhibitory-excitatory equilibrium and suggest that apart from static alterations rapid and dynamic neurochemical changes might also be relevant for the neural control of panic attacks.
According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine (Glx) levels were measured during cholecystokinin-tetrapeptide (CCK-4)-induced panic using magnetic resonance spectroscopy (MRS). Eighteen healthy subjects underwent a CCK-4 challenge. MR spectra were obtained from the anterior cingulate cortex (ACC) using a single voxel point-resolved spectroscopy method and analyzed using LCModel. A combined fitting of Glx was performed. Panic was assessed using the Acute Panic Inventory (API) and Panic Symptom Scale (PSS) scores. Moreover, hypothalamic-pituitary-adrenal axis stimulation was monitored throughout the challenge. There was a significant panic response following CCK-4 as revealed by a marked increase in both the panic scores (API: F(1,17)=149.41; p<0.0001; PSS: F(1,17)=88.03; p<0.0001) and heart rate (HR: F(1,17)=72.79; p<0.0001). MRS measures showed a significant increase of brain Glx/creatine (Glx/Cr) levels peaking at 2-10 min after challenge (F(1,17)=15.94; p=0.001). There was also a significant increase in CCK-4-related cortisol release (F(6,11)=8.68; p=0.002). Finally, significant positive correlations were found between baseline Glx/Cr and both API sub(max) (r=0.598; p=0.009) and maximum heart rate (HR sub(max)) during challenge (r=0.519; p=0.027). Our results suggest that CCK-4-induced panic is accompanied by a significant glutamate increase in the bilateral ACC. The results add to the hypothesis of a disturbance of the inhibitory-excitatory equilibrium and suggest that apart from static alterations rapid and dynamic neurochemical changes might also be relevant for the neural control of panic attacks.
According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine (Glx) levels were measured during cholecystokinin-tetrapeptide (CCK-4)-induced panic using magnetic resonance spectroscopy (MRS). Eighteen healthy subjects underwent a CCK-4 challenge. MR spectra were obtained from the anterior cingulate cortex (ACC) using a single voxel point-resolved spectroscopy method and analyzed using LCModel. A combined fitting of Glx was performed. Panic was assessed using the Acute Panic Inventory (API) and Panic Symptom Scale (PSS) scores. Moreover, hypothalamic-pituitary-adrenal axis stimulation was monitored throughout the challenge. There was a significant panic response following CCK-4 as revealed by a marked increase in both the panic scores (API: F(1,17)=149.41; p<0.0001; PSS: F(1,17)=88.03; p<0.0001) and heart rate (HR: F(1,17)=72.79; p<0.0001). MRS measures showed a significant increase of brain Glx/creatine (Glx/Cr) levels peaking at 2-10 min after challenge (F(1,17)=15.94; p=0.001). There was also a significant increase in CCK-4-related cortisol release (F(6,11)=8.68; p=0.002). Finally, significant positive correlations were found between baseline Glx/Cr and both APImax (r=0.598; p=0.009) and maximum heart rate (HR(max)) during challenge (r=0.519; p=0.027). Our results suggest that CCK-4-induced panic is accompanied by a significant glutamate increase in the bilateral ACC. The results add to the hypothesis of a disturbance of the inhibitory-excitatory equilibrium and suggest that apart from static alterations rapid and dynamic neurochemical changes might also be relevant for the neural control of panic attacks.According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine (Glx) levels were measured during cholecystokinin-tetrapeptide (CCK-4)-induced panic using magnetic resonance spectroscopy (MRS). Eighteen healthy subjects underwent a CCK-4 challenge. MR spectra were obtained from the anterior cingulate cortex (ACC) using a single voxel point-resolved spectroscopy method and analyzed using LCModel. A combined fitting of Glx was performed. Panic was assessed using the Acute Panic Inventory (API) and Panic Symptom Scale (PSS) scores. Moreover, hypothalamic-pituitary-adrenal axis stimulation was monitored throughout the challenge. There was a significant panic response following CCK-4 as revealed by a marked increase in both the panic scores (API: F(1,17)=149.41; p<0.0001; PSS: F(1,17)=88.03; p<0.0001) and heart rate (HR: F(1,17)=72.79; p<0.0001). MRS measures showed a significant increase of brain Glx/creatine (Glx/Cr) levels peaking at 2-10 min after challenge (F(1,17)=15.94; p=0.001). There was also a significant increase in CCK-4-related cortisol release (F(6,11)=8.68; p=0.002). Finally, significant positive correlations were found between baseline Glx/Cr and both APImax (r=0.598; p=0.009) and maximum heart rate (HR(max)) during challenge (r=0.519; p=0.027). Our results suggest that CCK-4-induced panic is accompanied by a significant glutamate increase in the bilateral ACC. The results add to the hypothesis of a disturbance of the inhibitory-excitatory equilibrium and suggest that apart from static alterations rapid and dynamic neurochemical changes might also be relevant for the neural control of panic attacks.
According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine (Glx) levels were measured during cholecystokinin-tetrapeptide (CCK-4)-induced panic using magnetic resonance spectroscopy (MRS). Eighteen healthy subjects underwent a CCK-4 challenge. MR spectra were obtained from the anterior cingulate cortex (ACC) using a single voxel point-resolved spectroscopy method and analyzed using LCModel. A combined fitting of Glx was performed. Panic was assessed using the Acute Panic Inventory (API) and Panic Symptom Scale (PSS) scores. Moreover, hypothalamic–pituitary–adrenal axis stimulation was monitored throughout the challenge. There was a significant panic response following CCK-4 as revealed by a marked increase in both the panic scores (API: F(1,17)=149.41; p <0.0001; PSS: F(1,17)=88.03; p <0.0001) and heart rate (HR: F(1,17)=72.79; p <0.0001). MRS measures showed a significant increase of brain Glx/creatine (Glx/Cr) levels peaking at 2–10 min after challenge (F(1,17)=15.94; p =0.001). There was also a significant increase in CCK-4-related cortisol release (F(6,11)=8.68; p =0.002). Finally, significant positive correlations were found between baseline Glx/Cr and both API max ( r =0.598; p =0.009) and maximum heart rate (HR max ) during challenge ( r =0.519; p =0.027). Our results suggest that CCK-4-induced panic is accompanied by a significant glutamate increase in the bilateral ACC. The results add to the hypothesis of a disturbance of the inhibitory–excitatory equilibrium and suggest that apart from static alterations rapid and dynamic neurochemical changes might also be relevant for the neural control of panic attacks.
Author Ohrmann, Patricia
Domschke, Katharina
Gencheva, Elena
Zavorotnyy, Maxim
Pfleiderer, Bettina
Ruland, Tillmann
Kugel, Harald
Diemer, Julia
Heindel, Walter
Arolt, Volker
Zwanzger, Peter
Author_xml – sequence: 1
  givenname: Peter
  surname: Zwanzger
  fullname: Zwanzger, Peter
– sequence: 2
  givenname: Maxim
  surname: Zavorotnyy
  fullname: Zavorotnyy, Maxim
– sequence: 3
  givenname: Elena
  surname: Gencheva
  fullname: Gencheva, Elena
– sequence: 4
  givenname: Julia
  surname: Diemer
  fullname: Diemer, Julia
– sequence: 5
  givenname: Harald
  surname: Kugel
  fullname: Kugel, Harald
– sequence: 6
  givenname: Walter
  surname: Heindel
  fullname: Heindel, Walter
– sequence: 7
  givenname: Tillmann
  surname: Ruland
  fullname: Ruland, Tillmann
– sequence: 8
  givenname: Patricia
  surname: Ohrmann
  fullname: Ohrmann, Patricia
– sequence: 9
  givenname: Volker
  surname: Arolt
  fullname: Arolt, Volker
– sequence: 10
  givenname: Katharina
  surname: Domschke
  fullname: Domschke, Katharina
– sequence: 11
  givenname: Bettina
  surname: Pfleiderer
  fullname: Pfleiderer, Bettina
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27618930$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23463151$$D View this record in MEDLINE/PubMed
BookMark eNqNkk2L1DAcxoOsuLOjJ-8SEEGQjknTpu1lYRj2DVYUZ4S9hTRNtxkzSW1Sd3vbD6Ff0E9iOjOuunjwFMjzy5P_y3MEDow1EoDnGM0wIvlb07azGGEyo_gRmOAsQRElydUBmKC8IBEm5OoQHDm3RginGc2fgMOYJJTgFE_A97novYTLRtUeKgPPdO_5hoerhTVCGt9xr6xx8NRqbW-UuYYnt63s1CZoXOsBXpiqF7KCH7hRAt4o38BFY7UUg_P2szLBdCWDTStbryr54-7bHJJV9O7jEi59Xw3jr-eSa98McNmXaym8ewoe11w7-Wx_TsGn05PV4jy6fH92sZhfRiJFqY8ylNEyIWVaZlWNqxLVEktEiwqVuCw4ihNMiirmQUiygqZVTkpSiiCSWOYiJVNwvPNt-3Ijq12_mrWhPd4NzHLF_laMati1_cpIhrM0uE_B671BZ7_00nm2UU5IrbmRtncMJ7gglKbF_6AI0TjJExTQlw_Qte07EyaxpXBYKxoNX_xZ_H3Vv5YbgFd7gDvBdd1xI5T7zWV06xS4NztOdNa5Ttb3CEZsjBgLEWNjxBgdXfEDWii_DUmYkNL_fPMTZazXQA
CODEN NEROEW
CitedBy_id crossref_primary_10_1017_neu_2021_41
crossref_primary_10_1038_s41398_024_02966_0
crossref_primary_10_3389_fpsyt_2021_813518
crossref_primary_10_1186_s12920_020_0699_9
crossref_primary_10_1016_j_neubiorev_2019_02_004
crossref_primary_10_3390_ijms23179628
crossref_primary_10_1002_biof_2081
crossref_primary_10_1038_npp_2014_104
crossref_primary_10_3390_cells13141228
crossref_primary_10_1192_j_eurpsy_2020_62
crossref_primary_10_1001_jamanetworkopen_2020_13211
crossref_primary_10_1177_0269881114563634
crossref_primary_10_1016_j_pscychresns_2014_03_001
crossref_primary_10_5498_wjp_v7_i1_12
crossref_primary_10_1016_j_neubiorev_2014_07_016
crossref_primary_10_1124_pr_114_009126
crossref_primary_10_1016_j_euroneuro_2015_07_011
crossref_primary_10_1016_j_jpsychires_2013_11_013
crossref_primary_10_1038_s41386_018_0027_7
crossref_primary_10_1016_j_bbadis_2020_165884
crossref_primary_10_1016_j_nicl_2017_01_001
crossref_primary_10_1016_j_pbb_2014_04_004
crossref_primary_10_1002_brb3_1616
crossref_primary_10_1038_npp_2014_93
crossref_primary_10_5702_massspectrometry_S0049
crossref_primary_10_1371_journal_pone_0136739
crossref_primary_10_1016_j_cortex_2019_02_021
crossref_primary_10_1124_pharmrev_120_000043
crossref_primary_10_1007_s11682_020_00259_w
Cites_doi 10.2174/138161208786848784
10.1016/S0006-3223(99)00159-6
10.1016/j.pbb.2011.04.010
10.1016/S0006-3223(99)00118-3
10.1016/0301-0082(95)00047-X
10.1016/S0006-3223(99)00230-9
10.1006/nimg.2002.1308
10.1007/978-3-642-68962-8
10.1001/archpsyc.55.8.715
10.1016/S0925-4927(03)00003-9
10.1016/j.neuroimage.2006.01.035
10.1038/nrd3295
10.1002/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G
10.1176/appi.ajp.159.1.145
10.1016/j.neuroimage.2006.10.004
10.1016/0165-1781(87)90002-3
10.1002/mrm.1910300604
10.1097/00001756-200502080-00024
10.1016/S0924-9338(97)83297-X
10.1176/ajp.151.2.261
10.1007/s00406-012-0352-5
10.1038/sj.npp.1300572
10.1038/37601
10.1001/archpsyc.60.2.161
10.1016/j.pscychresns.2009.02.005
10.1016/j.pnpbp.2011.05.006
10.1038/361031a0
10.2165/00023210-200822090-00004
10.1001/archpsyc.58.6.556
10.1001/archgenpsychiatry.2010.93
10.1016/j.pbb.2011.01.009
10.1001/archpsyc.65.10.1166
10.1016/j.cll.2010.07.006
10.1016/j.biopsych.2012.09.004
10.1126/science.1175055
10.1016/j.biopsych.2009.07.036
10.1016/S0091-3057(01)00698-0
10.1176/appi.ajp.2010.09070994
10.1002/1096-9861(20000703)422:3<352::AID-CNE3>3.0.CO;2-F
10.1192/bjp.176.3.229
10.2165/11533230-000000000-00000
10.1002/hbm.20522
10.1176/appi.ajp.157.4.493
10.1007/BF00589901
10.1001/archpsyc.55.9.801
10.1001/archpsyc.61.11.1136
10.1002/da.21919
10.1038/sj.npp.1300131
10.1001/archpsyc.56.11.1043
10.1016/S0924-977X(03)00100-7
10.1176/appi.ajp.162.12.2379
10.1001/archpsyc.1988.01800290027004
10.1016/j.neubiorev.2009.05.009
10.1038/sj.mp.4000778
10.1016/j.neuroimage.2011.05.048
ContentType Journal Article
Copyright 2015 INIST-CNRS
Copyright Nature Publishing Group Aug 2013
Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology
Copyright_xml – notice: 2015 INIST-CNRS
– notice: Copyright Nature Publishing Group Aug 2013
– notice: Copyright © 2013 American College of Neuropsychopharmacology 2013 American College of Neuropsychopharmacology
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1038/npp.2013.61
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology
Neurosciences Abstracts
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate Glutamate increase during induced panic attacks
EISSN 1740-634X
EndPage 1654
ExternalDocumentID PMC3717541
3020276571
23463151
27618930
10_1038_npp_2013_61
Genre Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Germany
GeographicLocations_xml – name: Germany
GroupedDBID ---
-DZ
-Q-
0R~
29N
2WC
36B
39C
4.4
406
5RE
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AANZL
AASML
AAYXX
AAYZH
ABAKF
ABBRH
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMFV
ACMJI
ACPRK
ACRQY
ACSTC
ACZOJ
ADBBV
ADFRT
AEFQL
AEJRE
AEMSY
AENEX
AESKC
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
ASPBG
ATHPR
AVWKF
AYFIA
AZFZN
AZQEC
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
CS3
DIK
DNIVK
DPUIP
DWQXO
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDB
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GNUQQ
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
MK0
NQJWS
O9-
OK1
P2P
P6G
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNT
RNTTT
ROL
RPM
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
UKHRP
W2D
ZGI
--K
1B1
53G
5VS
AACDK
AAEDT
AALRI
AAQFI
AAQXK
AATNV
AAXUO
ABMAC
ABWVN
ACIUM
ACRPL
ADMUD
ADNMO
AILAN
CAG
COF
FEDTE
FGOYB
FIGPU
HVGLF
IHE
IQODW
LGEZI
LOTEE
M41
NADUK
NQ-
NXXTH
R2-
RIG
RNS
RPZ
SEW
SSZ
ZKB
ABRTQ
ACVFH
ADCNI
AEUPX
AFPUW
AGQPQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
3V.
7TK
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c505t-7076b43b5b7df1db0fe1e069d0b1b9a024139d2ab0f47965d83b3bcb1b32e8c53
IEDL.DBID 7X7
ISSN 0893-133X
1740-634X
IngestDate Thu Aug 21 13:47:29 EDT 2025
Tue Aug 05 11:34:38 EDT 2025
Fri Jul 11 04:47:44 EDT 2025
Sat Aug 23 14:24:21 EDT 2025
Mon Jul 21 05:49:40 EDT 2025
Wed Apr 02 07:26:02 EDT 2025
Tue Jul 01 01:05:24 EDT 2025
Thu Apr 24 23:06:33 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Human
panic attacks
Panic
Healthy subject
Induction
Central nervous system
Anxiety disorder
magnetic resonance spectroscopy
Experimental study
Glutamate
Neuropeptide
Encephalon
Cingulate cortex
Panic attack
Excitatory aminoacid
Neurotransmitter
Anxiety
Cholecystokinin
CCK-4
anterior cingulate cortex
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c505t-7076b43b5b7df1db0fe1e069d0b1b9a024139d2ab0f47965d83b3bcb1b32e8c53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
These authors contributed equally to this work.
OpenAccessLink https://www.nature.com/articles/npp201361.pdf
PMID 23463151
PQID 1400189301
PQPubID 33935
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3717541
proquest_miscellaneous_1419366591
proquest_miscellaneous_1400624840
proquest_journals_1400189301
pubmed_primary_23463151
pascalfrancis_primary_27618930
crossref_primary_10_1038_npp_2013_61
crossref_citationtrail_10_1038_npp_2013_61
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-08-01
PublicationDateYYYYMMDD 2013-08-01
PublicationDate_xml – month: 08
  year: 2013
  text: 2013-08-01
  day: 01
PublicationDecade 2010
PublicationPlace Basingstoke
PublicationPlace_xml – name: Basingstoke
– name: England
– name: New York
PublicationTitle Neuropsychopharmacology (New York, N.Y.)
PublicationTitleAlternate Neuropsychopharmacology
PublicationYear 2013
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
References JC Ballenger (BFnpp201361_CR3) 1988; 45
MW Otto (BFnpp201361_CR35) 2010; 67
J Bradwejn (BFnpp201361_CR8) 1994; 151
R Rupprecht (BFnpp201361_CR45) 2010; 9
J Gallinat (BFnpp201361_CR15) 2007; 34
G Leicht (BFnpp201361_CR28) 2013; 73
C Nothdurfter (BFnpp201361_CR34) 2012; 262
G Hasler (BFnpp201361_CR19) 2008; 65
OD Creutzfeldt (BFnpp201361_CR10) 1983
JM Gorman (BFnpp201361_CR17) 2000; 157
D Eser (BFnpp201361_CR14) 2009; 30
P Zwanzger (BFnpp201361_CR58) 2003; 28
M Kellner (BFnpp201361_CR24) 2000; 47
RJ Maddock (BFnpp201361_CR29) 2011; 57
B Pfleiderer (BFnpp201361_CR37) 2002; 17
DP Auer (BFnpp201361_CR2) 2000; 47
MT Rogan (BFnpp201361_CR43) 1997; 390
J Shlik (BFnpp201361_CR51) 1997; 22
JH Krystal (BFnpp201361_CR27) 2010; 24
C Riaza Bermudo-Soriano (BFnpp201361_CR42) 2011; 100
Y Mashhoon (BFnpp201361_CR32) 2011; 35
MM Blanchard (BFnpp201361_CR6) 2009; 33
R Rupprecht (BFnpp201361_CR46) 2009; 325
AL Malizia (BFnpp201361_CR30) 1998; 55
A Strohle (BFnpp201361_CR53) 2002; 159
P Zwanzger (BFnpp201361_CR59) 2005; 30
KS White (BFnpp201361_CR56) 2002
DV Sheehan (BFnpp201361_CR50) 1997; 12
RC Kessler (BFnpp201361_CR25) 1998; 55
EI Martin (BFnpp201361_CR31) 2010; 30
SJ Mathew (BFnpp201361_CR33) 2005; 162
A Strohle (BFnpp201361_CR52) 2003; 60
DW Brann (BFnpp201361_CR9) 1997; 18
V Bergink (BFnpp201361_CR4) 2004; 14
D Eser (BFnpp201361_CR13) 2005; 30
G Hasler (BFnpp201361_CR20) 2010; 167
C Pittenger (BFnpp201361_CR39) 2008; 22
KJ Ressler (BFnpp201361_CR41) 2004; 61
PD Arnold (BFnpp201361_CR1) 2009; 172
TV Bliss (BFnpp201361_CR7) 1993; 361
PP Roy-Byrne (BFnpp201361_CR44) 2000; 176
K Domschke (BFnpp201361_CR12) 2008; 14
JM Stutzmann (BFnpp201361_CR54) 1989; 99
ID Grachev (BFnpp201361_CR18) 2000; 5
AW Goddard (BFnpp201361_CR16) 2001; 58
TE Salt (BFnpp201361_CR47) 1996; 48
G Sanacora (BFnpp201361_CR48) 1999; 56
DL Walker (BFnpp201361_CR55) 2002; 71
GB Kaplan (BFnpp201361_CR23) 2011; 99
JP Herman (BFnpp201361_CR21) 2000; 422
KL Phan (BFnpp201361_CR38) 2005; 16
RM Berman (BFnpp201361_CR5) 2000; 47
M Hoerst (BFnpp201361_CR22) 2010; 67
D Koszycki (BFnpp201361_CR26) 1998; 8
B Pfleiderer (BFnpp201361_CR36) 2003; 122
DJ Dillon (BFnpp201361_CR11) 1987; 20
SW Provencher (BFnpp201361_CR40) 1993; 30
T Schunck (BFnpp201361_CR49) 2006; 31
P Zwanzger (BFnpp201361_CR57) 2012; 29
9331548 - Endocr Rev. 1997 Oct;18(5):678-700
15520361 - Arch Gen Psychiatry. 2004 Nov;61(11):1136-44
12694892 - Psychiatry Res. 2003 Apr 1;122(3):185-92
21569789 - Pharmacol Biochem Behav. 2012 Feb;100(4):752-74
9707382 - Arch Gen Psychiatry. 1998 Aug;55(8):715-20
24939759 - Neuropsychopharmacology. 2014 Oct;39(11):2706
11386984 - Arch Gen Psychiatry. 2001 Jun;58(6):556-61
12498744 - Neuroimage. 2002 Dec;17(4):1705-10
20603446 - Arch Gen Psychiatry. 2010 Sep;67(9):946-54
11032381 - Mol Psychiatry. 2000 Sep;5(5):482-8
9401314 - J Psychiatry Neurosci. 1997 Nov;22(5):332-40
3575564 - Psychiatry Res. 1987 Feb;20(2):97-105
20832657 - Clin Lab Med. 2010 Dec;30(4):865-91
8830348 - Prog Neurobiol. 1996 Jan;48(1):55-72
15944741 - J Psychiatry Neurosci. 2005 May;30(3):167-75
8296900 - Am J Psychiatry. 1994 Feb;151(2):261-3
16330605 - Am J Psychiatry. 2005 Dec;162(12):2379-81
15056476 - Eur Neuropsychopharmacol. 2004 May;14(3):175-83
10565505 - Arch Gen Psychiatry. 1999 Nov;56(11):1043-7
2574482 - Psychopharmacology (Berl). 1989;99(4):515-9
9403688 - Nature. 1997 Dec 11;390(6660):604-7
10739407 - Am J Psychiatry. 2000 Apr;157(4):493-505
18838633 - Arch Gen Psychiatry. 2008 Oct;65(10):1166-75
22923187 - Eur Arch Psychiatry Clin Neurosci. 2012 Nov;262 Suppl 2:S107-12
22553078 - Depress Anxiety. 2012 Sep;29(9):762-74
10861512 - J Comp Neurol. 2000 Jul 3;422(3):352-62
23059050 - Biol Psychiatry. 2013 Feb 15;73(4):337-44
21616118 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1709-13
12578433 - Arch Gen Psychiatry. 2003 Feb;60(2):161-8
15467707 - Neuropsychopharmacology. 2005 Jan;30(1):192-5
20634372 - Am J Psychiatry. 2010 Oct;167(10):1226-31
10755069 - Br J Psychiatry. 2000 Mar;176:229-35
11772707 - Am J Psychiatry. 2002 Jan;159(1):145-7
9736006 - Arch Gen Psychiatry. 1998 Sep;55(9):801-8
21256147 - Pharmacol Biochem Behav. 2011 Aug;99(2):217-28
15671874 - Neuroreport. 2005 Feb 8;16(2):183-6
21640838 - Neuroimage. 2011 Aug 15;57(4):1324-30
19811776 - Biol Psychiatry. 2010 Feb 15;67(4):365-70
10686270 - Biol Psychiatry. 2000 Feb 15;47(4):351-4
16600640 - Neuroimage. 2006 Jul 1;31(3):1197-208
10686265 - Biol Psychiatry. 2000 Feb 15;47(4):305-13
17123835 - Neuroimage. 2007 Jan 15;34(2):671-8
8139448 - Magn Reson Med. 1993 Dec;30(6):672-9
9750972 - Depress Anxiety. 1998;8(1):1-7
19324536 - Psychiatry Res. 2009 May 15;172(2):136-9
19497336 - Neurosci Biobehav Rev. 2009 Jul;33(7):1145-54
19075727 - Curr Pharm Des. 2008;14(33):3508-17
3282478 - Arch Gen Psychiatry. 1988 May;45(5):413-22
12700707 - Neuropsychopharmacology. 2003 May;28(5):979-84
8421494 - Nature. 1993 Jan 7;361(6407):31-9
24939760 - Neuropsychopharmacology. 2014 Oct;39(11):2707-8
21119734 - Nat Rev Drug Discov. 2010 Dec;9(12):971-88
11830172 - Pharmacol Biochem Behav. 2002 Mar;71(3):379-92
10664826 - Biol Psychiatry. 2000 Jan 15;47(2):107-11
18698875 - CNS Drugs. 2008;22(9):761-86
18095276 - Hum Brain Mapp. 2009 Feb;30(2):511-22
20658799 - CNS Drugs. 2010 Aug;24(8):669-93
19541954 - Science. 2009 Jul 24;325(5939):490-3
References_xml – volume: 14
  start-page: 3508
  year: 2008
  ident: BFnpp201361_CR12
  publication-title: Curr Pharm Des
  doi: 10.2174/138161208786848784
– volume: 47
  start-page: 305
  year: 2000
  ident: BFnpp201361_CR2
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00159-6
– volume: 100
  start-page: 752
  year: 2011
  ident: BFnpp201361_CR42
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/j.pbb.2011.04.010
– volume: 47
  start-page: 107
  year: 2000
  ident: BFnpp201361_CR24
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00118-3
– volume: 48
  start-page: 55
  year: 1996
  ident: BFnpp201361_CR47
  publication-title: Prog Neurobiol
  doi: 10.1016/0301-0082(95)00047-X
– volume: 47
  start-page: 351
  year: 2000
  ident: BFnpp201361_CR5
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(99)00230-9
– volume: 17
  start-page: 1705
  year: 2002
  ident: BFnpp201361_CR37
  publication-title: Neuroimage
  doi: 10.1006/nimg.2002.1308
– start-page: 47
  volume-title: Cortex Cerebri
  year: 1983
  ident: BFnpp201361_CR10
  doi: 10.1007/978-3-642-68962-8
– volume: 55
  start-page: 715
  year: 1998
  ident: BFnpp201361_CR30
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.55.8.715
– volume: 122
  start-page: 185
  year: 2003
  ident: BFnpp201361_CR36
  publication-title: Psychiatr Res Neuroimaging
  doi: 10.1016/S0925-4927(03)00003-9
– start-page: 328
  volume-title: Anxiety and its Disorders
  year: 2002
  ident: BFnpp201361_CR56
– volume: 31
  start-page: 1197
  year: 2006
  ident: BFnpp201361_CR49
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2006.01.035
– volume: 9
  start-page: 971
  year: 2010
  ident: BFnpp201361_CR45
  publication-title: Nat Rev Drug Discov
  doi: 10.1038/nrd3295
– volume: 8
  start-page: 1
  year: 1998
  ident: BFnpp201361_CR26
  publication-title: Depress Anxiety
  doi: 10.1002/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G
– volume: 159
  start-page: 145
  year: 2002
  ident: BFnpp201361_CR53
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.159.1.145
– volume: 34
  start-page: 671
  year: 2007
  ident: BFnpp201361_CR15
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2006.10.004
– volume: 20
  start-page: 97
  year: 1987
  ident: BFnpp201361_CR11
  publication-title: Psychiatry Res
  doi: 10.1016/0165-1781(87)90002-3
– volume: 30
  start-page: 672
  year: 1993
  ident: BFnpp201361_CR40
  publication-title: Magn Reson Med
  doi: 10.1002/mrm.1910300604
– volume: 16
  start-page: 183
  year: 2005
  ident: BFnpp201361_CR38
  publication-title: Neuroreport
  doi: 10.1097/00001756-200502080-00024
– volume: 12
  start-page: 232
  year: 1997
  ident: BFnpp201361_CR50
  publication-title: Eur Psychiatry
  doi: 10.1016/S0924-9338(97)83297-X
– volume: 151
  start-page: 261
  year: 1994
  ident: BFnpp201361_CR8
  publication-title: Am J Psychiatry
  doi: 10.1176/ajp.151.2.261
– volume: 262
  start-page: 107
  issue: Suppl 2
  year: 2012
  ident: BFnpp201361_CR34
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-012-0352-5
– volume: 30
  start-page: 192
  year: 2005
  ident: BFnpp201361_CR13
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300572
– volume: 390
  start-page: 604
  year: 1997
  ident: BFnpp201361_CR43
  publication-title: Nature
  doi: 10.1038/37601
– volume: 60
  start-page: 161
  year: 2003
  ident: BFnpp201361_CR52
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.60.2.161
– volume: 172
  start-page: 136
  year: 2009
  ident: BFnpp201361_CR1
  publication-title: Psychiatry Res
  doi: 10.1016/j.pscychresns.2009.02.005
– volume: 30
  start-page: 167
  year: 2005
  ident: BFnpp201361_CR59
  publication-title: J Psychiatry Neurosci
– volume: 18
  start-page: 678
  year: 1997
  ident: BFnpp201361_CR9
  publication-title: Endocr Rev
– volume: 35
  start-page: 1709
  year: 2011
  ident: BFnpp201361_CR32
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2011.05.006
– volume: 361
  start-page: 31
  year: 1993
  ident: BFnpp201361_CR7
  publication-title: Nature
  doi: 10.1038/361031a0
– volume: 22
  start-page: 761
  year: 2008
  ident: BFnpp201361_CR39
  publication-title: CNS Drugs
  doi: 10.2165/00023210-200822090-00004
– volume: 58
  start-page: 556
  year: 2001
  ident: BFnpp201361_CR16
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.58.6.556
– volume: 67
  start-page: 946
  year: 2010
  ident: BFnpp201361_CR22
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archgenpsychiatry.2010.93
– volume: 99
  start-page: 217
  year: 2011
  ident: BFnpp201361_CR23
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/j.pbb.2011.01.009
– volume: 65
  start-page: 1166
  year: 2008
  ident: BFnpp201361_CR19
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.65.10.1166
– volume: 30
  start-page: 865
  year: 2010
  ident: BFnpp201361_CR31
  publication-title: Clin Lab Med
  doi: 10.1016/j.cll.2010.07.006
– volume: 73
  start-page: 337
  year: 2013
  ident: BFnpp201361_CR28
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2012.09.004
– volume: 22
  start-page: 332
  year: 1997
  ident: BFnpp201361_CR51
  publication-title: J Psychiatry Neurosci
– volume: 325
  start-page: 490
  year: 2009
  ident: BFnpp201361_CR46
  publication-title: Science
  doi: 10.1126/science.1175055
– volume: 67
  start-page: 365
  year: 2010
  ident: BFnpp201361_CR35
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2009.07.036
– volume: 71
  start-page: 379
  year: 2002
  ident: BFnpp201361_CR55
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/S0091-3057(01)00698-0
– volume: 167
  start-page: 1226
  year: 2010
  ident: BFnpp201361_CR20
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.2010.09070994
– volume: 422
  start-page: 352
  year: 2000
  ident: BFnpp201361_CR21
  publication-title: J Comp Neurol
  doi: 10.1002/1096-9861(20000703)422:3<352::AID-CNE3>3.0.CO;2-F
– volume: 176
  start-page: 229
  year: 2000
  ident: BFnpp201361_CR44
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.176.3.229
– volume: 24
  start-page: 669
  year: 2010
  ident: BFnpp201361_CR27
  publication-title: CNS Drugs
  doi: 10.2165/11533230-000000000-00000
– volume: 30
  start-page: 511
  year: 2009
  ident: BFnpp201361_CR14
  publication-title: Hum Brain Mapp
  doi: 10.1002/hbm.20522
– volume: 157
  start-page: 493
  year: 2000
  ident: BFnpp201361_CR17
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.157.4.493
– volume: 99
  start-page: 515
  year: 1989
  ident: BFnpp201361_CR54
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/BF00589901
– volume: 55
  start-page: 801
  year: 1998
  ident: BFnpp201361_CR25
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.55.9.801
– volume: 61
  start-page: 1136
  year: 2004
  ident: BFnpp201361_CR41
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.61.11.1136
– volume: 29
  start-page: 762
  year: 2012
  ident: BFnpp201361_CR57
  publication-title: Depress Anxiety
  doi: 10.1002/da.21919
– volume: 28
  start-page: 979
  year: 2003
  ident: BFnpp201361_CR58
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300131
– volume: 56
  start-page: 1043
  year: 1999
  ident: BFnpp201361_CR48
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.56.11.1043
– volume: 14
  start-page: 175
  year: 2004
  ident: BFnpp201361_CR4
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/S0924-977X(03)00100-7
– volume: 162
  start-page: 2379
  year: 2005
  ident: BFnpp201361_CR33
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.162.12.2379
– volume: 45
  start-page: 413
  year: 1988
  ident: BFnpp201361_CR3
  publication-title: Arch Gen Psychiatry
  doi: 10.1001/archpsyc.1988.01800290027004
– volume: 33
  start-page: 1145
  year: 2009
  ident: BFnpp201361_CR6
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2009.05.009
– volume: 5
  start-page: 482
  year: 2000
  ident: BFnpp201361_CR18
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4000778
– volume: 57
  start-page: 1324
  year: 2011
  ident: BFnpp201361_CR29
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2011.05.048
– reference: 9401314 - J Psychiatry Neurosci. 1997 Nov;22(5):332-40
– reference: 21640838 - Neuroimage. 2011 Aug 15;57(4):1324-30
– reference: 15671874 - Neuroreport. 2005 Feb 8;16(2):183-6
– reference: 8421494 - Nature. 1993 Jan 7;361(6407):31-9
– reference: 12578433 - Arch Gen Psychiatry. 2003 Feb;60(2):161-8
– reference: 16600640 - Neuroimage. 2006 Jul 1;31(3):1197-208
– reference: 18095276 - Hum Brain Mapp. 2009 Feb;30(2):511-22
– reference: 8139448 - Magn Reson Med. 1993 Dec;30(6):672-9
– reference: 9736006 - Arch Gen Psychiatry. 1998 Sep;55(9):801-8
– reference: 21256147 - Pharmacol Biochem Behav. 2011 Aug;99(2):217-28
– reference: 19324536 - Psychiatry Res. 2009 May 15;172(2):136-9
– reference: 18698875 - CNS Drugs. 2008;22(9):761-86
– reference: 15056476 - Eur Neuropsychopharmacol. 2004 May;14(3):175-83
– reference: 11830172 - Pharmacol Biochem Behav. 2002 Mar;71(3):379-92
– reference: 8296900 - Am J Psychiatry. 1994 Feb;151(2):261-3
– reference: 10664826 - Biol Psychiatry. 2000 Jan 15;47(2):107-11
– reference: 11032381 - Mol Psychiatry. 2000 Sep;5(5):482-8
– reference: 3282478 - Arch Gen Psychiatry. 1988 May;45(5):413-22
– reference: 9707382 - Arch Gen Psychiatry. 1998 Aug;55(8):715-20
– reference: 19497336 - Neurosci Biobehav Rev. 2009 Jul;33(7):1145-54
– reference: 19811776 - Biol Psychiatry. 2010 Feb 15;67(4):365-70
– reference: 15520361 - Arch Gen Psychiatry. 2004 Nov;61(11):1136-44
– reference: 11386984 - Arch Gen Psychiatry. 2001 Jun;58(6):556-61
– reference: 9331548 - Endocr Rev. 1997 Oct;18(5):678-700
– reference: 19541954 - Science. 2009 Jul 24;325(5939):490-3
– reference: 15467707 - Neuropsychopharmacology. 2005 Jan;30(1):192-5
– reference: 10565505 - Arch Gen Psychiatry. 1999 Nov;56(11):1043-7
– reference: 18838633 - Arch Gen Psychiatry. 2008 Oct;65(10):1166-75
– reference: 8830348 - Prog Neurobiol. 1996 Jan;48(1):55-72
– reference: 23059050 - Biol Psychiatry. 2013 Feb 15;73(4):337-44
– reference: 12694892 - Psychiatry Res. 2003 Apr 1;122(3):185-92
– reference: 17123835 - Neuroimage. 2007 Jan 15;34(2):671-8
– reference: 24939760 - Neuropsychopharmacology. 2014 Oct;39(11):2707-8
– reference: 11772707 - Am J Psychiatry. 2002 Jan;159(1):145-7
– reference: 10755069 - Br J Psychiatry. 2000 Mar;176:229-35
– reference: 24939759 - Neuropsychopharmacology. 2014 Oct;39(11):2706
– reference: 22923187 - Eur Arch Psychiatry Clin Neurosci. 2012 Nov;262 Suppl 2:S107-12
– reference: 3575564 - Psychiatry Res. 1987 Feb;20(2):97-105
– reference: 10686265 - Biol Psychiatry. 2000 Feb 15;47(4):305-13
– reference: 2574482 - Psychopharmacology (Berl). 1989;99(4):515-9
– reference: 12498744 - Neuroimage. 2002 Dec;17(4):1705-10
– reference: 22553078 - Depress Anxiety. 2012 Sep;29(9):762-74
– reference: 20603446 - Arch Gen Psychiatry. 2010 Sep;67(9):946-54
– reference: 21616118 - Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1709-13
– reference: 10861512 - J Comp Neurol. 2000 Jul 3;422(3):352-62
– reference: 10739407 - Am J Psychiatry. 2000 Apr;157(4):493-505
– reference: 16330605 - Am J Psychiatry. 2005 Dec;162(12):2379-81
– reference: 20634372 - Am J Psychiatry. 2010 Oct;167(10):1226-31
– reference: 10686270 - Biol Psychiatry. 2000 Feb 15;47(4):351-4
– reference: 12700707 - Neuropsychopharmacology. 2003 May;28(5):979-84
– reference: 21119734 - Nat Rev Drug Discov. 2010 Dec;9(12):971-88
– reference: 9403688 - Nature. 1997 Dec 11;390(6660):604-7
– reference: 9750972 - Depress Anxiety. 1998;8(1):1-7
– reference: 19075727 - Curr Pharm Des. 2008;14(33):3508-17
– reference: 20832657 - Clin Lab Med. 2010 Dec;30(4):865-91
– reference: 20658799 - CNS Drugs. 2010 Aug;24(8):669-93
– reference: 21569789 - Pharmacol Biochem Behav. 2012 Feb;100(4):752-74
– reference: 15944741 - J Psychiatry Neurosci. 2005 May;30(3):167-75
SSID ssj0015768
Score 2.2406497
Snippet According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1648
SubjectTerms Adrenocorticotropic Hormone - blood
Adult
Adult and adolescent clinical studies
Anxiety disorders
Anxiety disorders. Neuroses
Benzodiazepines
Biological and medical sciences
Brain research
Creatine - metabolism
Functional Neuroimaging
Glutamic Acid - metabolism
Glutamine - metabolism
Gyrus Cinguli - metabolism
Heart Rate
Hormones
Humans
Hydrocortisone - blood
Hypothalamo-Hypophyseal System - metabolism
Male
Medical sciences
Neurobiology
Original
Panic attacks
Panic disorder
Panic Disorder - blood
Panic Disorder - chemically induced
Panic Disorder - metabolism
Pathogenesis
Pituitary-Adrenal System - metabolism
Psychiatric Status Rating Scales
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychotherapy
Signal transduction
Spectrum analysis
Tetragastrin
Title Acute Shift in Glutamate Concentrations Following Experimentally Induced Panic with Cholecystokinin Tetrapeptide—A 3T-MRS Study in Healthy Subjects
URI https://www.ncbi.nlm.nih.gov/pubmed/23463151
https://www.proquest.com/docview/1400189301
https://www.proquest.com/docview/1400624840
https://www.proquest.com/docview/1419366591
https://pubmed.ncbi.nlm.nih.gov/PMC3717541
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9swFBZbC2NQxpbu4q0LGpQ-jGq1LUu2n0YWkpVBSmhTyJuxZJmGdU46Owz_j_3gnSM7TjNKX_yik1hYR9J3rh8hxyE3Oshzw0wufBZk8Eh9lbM8EHAhYmRNYYHz5EKeXwc_5mLeOtzKNq1ycybagzpbavSRn4Eh4Hpwubre19UdQ9YojK62FBpPyT62LsOUrnDeGVweYmmLImPOwBabt_V5Lo_OihU2q_T4F-nt3EgHq7SEj5M3rBYPwc7_syfvXUfjl-RFiyPpoFn4V-SJKXrkcFCADf2rpifUZnZal3mPPJu0AfQeOZk2rarrUzrbVl6Vp_YXXRPr-pD8Heh1ZejVzSKv6KKg30FDU0C3hg6x0LFou-2WdAyKtPwDFyAd3SMLuK0pkoJok9FpWiw0RX8vHVoy3hrw5k_kpaAzU-EU4NTKDGMDymdscnlFMbexxpc2NVI1hdMN3UXla3I9Hs2G56xlcGAakFXFQjeUKuBKqDDLvUy5ufGMK-PMVZ6KUxeDenHmpzAQhLEUWcQVVxoGuW8iLfgbslcsC_OOUIVITYNBZ1KB0doUkJ5IXaF45Gc6Dx3yebOKiW7bmyPLxm1iw-w8SmDJE1zyRHoOOe6EV01Xj4fF-jvq0Mn6obS66JCjjX4k7d4vk62mOuRTNwy7FkMxaWGW60ZG-gFY14_JALiWUsTwP28bldtOgAeSA1hzSLijjJ0Adg3fHSkWN7Z7OAcDXgTe-8en_oE89y3xB6Y6HpG96vfafAT4Vam-3WN9sv9tdDG9_AfAczRg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEB5VrQRICEHKT6CURSo9oC61vf6JDwiFkJDSJoraVMrNeNdrNaI4ATuq_B48B8_IjO04Dap66yWXnSQrzezMNzs78wHseUIrO44117FjcTvCj9CSMY9tBwMiVdYkNTgPhm7_3P42cSYb8HfZC0PPKpc-sXDU0UzRHfkhJgKGicHVMD_Nf3FijaLq6pJCozSLY51fYcqWfjz6gvp9Z1m97rjT5xWrAFcY7TPuYeYubSEd6UWxGUkj1qY2XD8ypCn90KBCkx9ZIS7Ynu86UUtIIRUuCku3FLFEoMvfsgWmMpuw9bk7HJ3WdQtC7wVu9QXH7G9SdQQaonWYzGk8pik-uOZaDHw4D1NUR1zyaNwEdP9_r3ktAPYew6MKubJ2aWpPYEMnDdhuJ5i1_8zZPivekhaX9A24N6hK9g3YH5XDsfMDNl71eqUHxTfqsdn5Nvxpq0Wm2dnFNM7YNGFf8UyEiKc161BrZVLN901ZD013doUhl3Wv0RNc5oxoSJSO2ChMporRDTPrFPS_OSLcH8SEwcY6oy2gn4w0520mxnxwesboNWVOf1p2ZeUM_SldUKVP4fxOtPsMNpNZol8Ak4QNFaaQOnSoPhwitnRCw5GiZUUq9prwfqnFQFUD1YnX4zIoCvuiFaDKA1J54JpN2KuF5-UckZvFdtfMoZa1PLew_ibsLO0jqLxNGqzORhPe1svoJ6j4EyZ6tihlXMvGfP42GYTzruv4-DvPS5NbbUDYrkB42ARvzRhrAZpTvr6STC-KeeXCQ4xqmy9v3_obuN8fD06Ck6Ph8St4YBW0I_TQcgc2s98L_RrBXyZ3qxPH4PtdH_J_ZKdxUQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamIU1ICEHHpTCGkcYe0LzGcS7NA0JVt7IxOlWsk_oWYsfWKkZaSKop_4Nfw6_jHCfNVjTtbS998Wlr6dy-43MjZCcUWnnGaKaN7zIvhY_ElYYZzweHiJk1iQ3Ow9Pg6Nz7MvEna-TvshcGyyqXNtEa6nSm8I28A4GAw8G5Orxj6rKI0cHg0_wXww1SmGldrtOoROREl1cQvuUfjw-A1-9dd3A47h-xesMAU-D5CxZCFC89IX0Zpoan0jGaayeIUkdyGSUOJp2i1E3gwAujwE-7Qgqp4FC4uqtwYwSY_weh8DnqWDhpgj2OON4i2EgwiAMndW-gI7qdbI6DMrnYD_iKN3w0T3JgjKk2atwGef-v3LzhCgdPyOMaw9JeJXRPyZrOWmSzl0H8_rOku9RWldrn-hbZGNbJ-xbZHVVjsss9Or7u-sr37DeaAdrlJvnTU4tC07OLqSnoNKOfQTsSQNaa9rHJMqsn_eZ0AEI8uwLnSw9vLCq4LCkuJFE6paMkmyqKb820bxcBl4B1f-BODDrWBV4BLGaqGetRMWbDb2cU6ypL_NOqP6ukYFnxqSp_Rs7vhbfPyXo2y_RLQiWiRAXBpE58zBQngDL9xPGl6LqpMmGbfFhyMVb1aHXc8HEZ2xS_6MbA8hhZHge8TXYa4nk1UeR2su0VcWho3TCwetAmW0v5iGu7k8fXWtIm75pjsBiYBkoyPVtUNIHrQWR_Fw0A-yDwI_idF5XIXV9AeIEAoNgm4YowNgQ4sXz1JJte2MnlIgS06vFXd1_9LdkA1Y6_Hp-evCYPXbt_BCsut8h68Xuh3wAKLOS2VTdKvt-3fv8DNqR0IQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acute+Shift+in+Glutamate+Concentrations+Following+Experimentally+Induced+Panic+with+Cholecystokinin+Tetrapeptide-A+3T-MRS+Study+in+Healthy+Subjects&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Zwanzger%2C+Peter&rft.au=Zavorotnyy%2C+Maxim&rft.au=Gencheva%2C+Elena&rft.au=Diemer%2C+Julia&rft.date=2013-08-01&rft.issn=0893-133X&rft.volume=38&rft.issue=9&rft.spage=1648&rft.epage=1654&rft_id=info:doi/10.1038%2Fnpp.2013.61&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon